66 related articles for article (PubMed ID: 3392664)
1. Effects of chronic phenobarbital on verapamil disposition in humans.
Rutledge DR; Pieper JA; Mirvis DM
J Pharmacol Exp Ther; 1988 Jul; 246(1):7-13. PubMed ID: 3392664
[TBL] [Abstract][Full Text] [Related]
2. Increased clearance of antipyrine and d-propranolol after phenobarbital treatment in the monkey. Relative contributions of enzyme induction and increased hepatic blood flow.
Branch RA; Shand DG; Wilkinson GR; Nies AS
J Clin Invest; 1974 Apr; 53(4):1101-7. PubMed ID: 4205524
[TBL] [Abstract][Full Text] [Related]
3. Differential induction of prehepatic and hepatic metabolism of verapamil by rifampin.
Fromm MF; Busse D; Kroemer HK; Eichelbaum M
Hepatology; 1996 Oct; 24(4):796-801. PubMed ID: 8855178
[TBL] [Abstract][Full Text] [Related]
4. Stereoselective verapamil disposition and dynamics in aging during racemic verapamil administration.
Abernethy DR; Wainer IW; Longstreth JA; Andrawis NS
J Pharmacol Exp Ther; 1993 Aug; 266(2):904-11. PubMed ID: 8355215
[TBL] [Abstract][Full Text] [Related]
5. Interaction of verapamil and cimetidine: stereochemical aspects of drug metabolism, drug disposition and drug action.
Mikus G; Eichelbaum M; Fischer C; Gumulka S; Klotz U; Kroemer HK
J Pharmacol Exp Ther; 1990 Jun; 253(3):1042-8. PubMed ID: 2359015
[TBL] [Abstract][Full Text] [Related]
6. Faster clearance of sustained release verapamil in men versus women: continuing observations on sex-specific differences after oral administration of verapamil.
Krecic-Shepard ME; Barnas CR; Slimko J; Schwartz JB
Clin Pharmacol Ther; 2000 Sep; 68(3):286-92. PubMed ID: 11014410
[TBL] [Abstract][Full Text] [Related]
7. Effect of butalbital and phenobarbital pretreatment on antipyrine clearance in the rat.
Tse FL; Chang T; Jaffe JM
Arch Int Pharmacodyn Ther; 1986 Feb; 279(2):181-94. PubMed ID: 3963935
[TBL] [Abstract][Full Text] [Related]
8. Interactions of phenobarbital with propranolol in the dog. 2. Bioavailability, metabolism and pharmacokinetics.
Vu VT; Bai SA; Abramson FP
J Pharmacol Exp Ther; 1983 Jan; 224(1):55-61. PubMed ID: 6848749
[TBL] [Abstract][Full Text] [Related]
9. Effect of concomitant administration of cimetidine and phenobarbital on antipyrine elimination and metabolite formation.
Sonne J; Døssing M; Poulsen HE; Pilsgaard H; Rasmussen B; Loft S
Int J Clin Pharmacol Ther Toxicol; 1987 Apr; 25(4):194-6. PubMed ID: 3583468
[TBL] [Abstract][Full Text] [Related]
10. Phenobarbital in the genetically obese Zucker rat. II. In vivo and in vitro assessments of microsomal enzyme induction.
Brouwer KL; Kostenbauder HB; McNamara PJ; Blouin RA
J Pharmacol Exp Ther; 1984 Dec; 231(3):654-9. PubMed ID: 6502519
[TBL] [Abstract][Full Text] [Related]
11. Substrate-selective inhibition by verapamil and diltiazem: differential disposition of antipyrine and theophylline in humans.
Abernethy DR; Egan JM; Dickinson TH; Carrum G
J Pharmacol Exp Ther; 1988 Mar; 244(3):994-9. PubMed ID: 3252045
[TBL] [Abstract][Full Text] [Related]
12. Differential effect of cimetidine on drug oxidation (antipyrine and diazepam) vs. conjugation (acetaminophen and lorazepam): prevention of acetaminophen toxicity by cimetidine.
Abernethy DR; Greenblatt DJ; Divoll M; Ameer B; Shader RI
J Pharmacol Exp Ther; 1983 Mar; 224(3):508-13. PubMed ID: 6827475
[TBL] [Abstract][Full Text] [Related]
13. The effect of age, sex, and rifampin administration on intestinal and hepatic cytochrome P450 3A activity.
Gorski JC; Vannaprasaht S; Hamman MA; Ambrosius WT; Bruce MA; Haehner-Daniels B; Hall SD
Clin Pharmacol Ther; 2003 Sep; 74(3):275-87. PubMed ID: 12966371
[TBL] [Abstract][Full Text] [Related]
14. Phenobarbital in the genetically obese Zucker rat. I. Pharmacokinetics after acute and chronic administration.
Brouwer KL; Kostenbauder HB; McNamara PJ; Blouin RA
J Pharmacol Exp Ther; 1984 Dec; 231(3):649-53. PubMed ID: 6502518
[TBL] [Abstract][Full Text] [Related]
15. Effects of liver fibrosis on verapamil pharmacokinetics in rats.
Chen M; Xu D; Hu XL; Wang H
Clin Exp Pharmacol Physiol; 2008 Mar; 35(3):287-94. PubMed ID: 17973928
[TBL] [Abstract][Full Text] [Related]
16. Effects of a 44-day administration of phenobarbital on disposition of clorazepate in dogs.
Forrester SD; Wilcke JR; Jacobson JD; Dyer KR
Am J Vet Res; 1993 Jul; 54(7):1136-8. PubMed ID: 8368611
[TBL] [Abstract][Full Text] [Related]
17. [Pharmacokinetics of verapamil and its N-dealkylated metabolites in patients with chronic ischemic heart disease undergoing long-term monotherapy].
Rumiantsev DO; Piotrovskiĭ VK; Metelitsa VI; Riabokon' OS; Kokurina EV
Farmakol Toksikol; 1988; 51(1):66-70. PubMed ID: 3360112
[TBL] [Abstract][Full Text] [Related]
18. Verapamil stereoisomerism: enantiomeric ratios in plasma dependent on peak concentrations, oral input rate, or both.
Karim A; Piergies A
Clin Pharmacol Ther; 1995 Aug; 58(2):174-84. PubMed ID: 7648767
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteers.
Bergman AJ; Stevens C; Zhou Y; Yi B; Laethem M; De Smet M; Snyder K; Hilliard D; Tanaka W; Zeng W; Tanen M; Wang AQ; Chen L; Winchell G; Davies MJ; Ramael S; Wagner JA; Herman GA
Clin Ther; 2006 Jan; 28(1):55-72. PubMed ID: 16490580
[TBL] [Abstract][Full Text] [Related]
20. Unexpected effect of verapamil on oral bioavailability of the beta-blocker talinolol in humans.
Schwarz UI; Gramatté T; Krappweis J; Berndt A; Oertel R; von Richter O; Kirch W
Clin Pharmacol Ther; 1999 Mar; 65(3):283-90. PubMed ID: 10096260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
